Buoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Cardiothoracic surgeon Dr. Scally with Prairie Cardiovascular in O’Fallon, Illinois, explained Mitral Valve Disease, a ...

Mitral valve replacement in children traditionally uses non-living tissue or mechanical valves, neither of which grow as a ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

C Medical Technologies has closed its Series D financing round. which was led by Boston Scientific, raising gross proceeds of ...

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...

From valve repair with MitraClip to advanced aortic-disease solutions, Malaysia’s largest heart hospital is transforming ...

Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced today ...

We’re not doing this to reduce their mitral regurgitation. We’re doing this to make them feel better ... is that “here is some data that suggests that, yes, it’s beneficial in heart failure, but it ...